{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:05:29Z","timestamp":1778497529357,"version":"3.51.4"},"reference-count":10,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.3201\/eid2506.181928","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T15:17:45Z","timestamp":1553267865000},"page":"1238-1240","source":"Crossref","is-referenced-by-count":2,"title":["Suboptimal Handling of Piccolo Samples or Reagent Discs for Consideration in Ebola Response"],"prefix":"10.3201","volume":"25","author":[{"given":"Jessica R.","family":"Spengler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah C.","family":"Genzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn","family":"Coleman-McCray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica R.","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart T.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2506.181928-201905191612-R1","doi-asserted-by":"publisher","first-page":"e0005545","DOI":"10.1371\/journal.pntd.0005545","article-title":"Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa.","volume":"11","author":"Carazo Perez","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2506.181928-201905191612-R2","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.clinbiochem.2015.08.002","article-title":"Analytical performance of the Abaxis Piccolo Xpress\u00ae point of care analyzer in whole blood, serum, and plasma.","volume":"48","author":"Murata","year":"2015","journal-title":"Clin Biochem"},{"key":"key-10.3201\/eid2506.181928-201905191612-R3","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1093\/infdis\/jiw216","article-title":"Ebola laboratory response at the Eternal Love Winning Africa campus, Monrovia, Liberia, 2014\u20132015.","volume":"214","author":"de Wit","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2506.181928-201905191612-R4","doi-asserted-by":"publisher","first-page":"S303","DOI":"10.1093\/infdis\/jiw187","article-title":"Clinical chemistry of patients with Ebola in Monrovia, Liberia.","volume":"214","author":"de Wit","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2506.181928-201905191612-R5","doi-asserted-by":"crossref","unstructured":"Sissoko D, Laouenan C, Folkesson E, M\u2019Lebing A-B, Beavogui A-H, Baize S, ; JIKI Study Group. Experimental treatment with favipiravir for Ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med. 2016;13:e1001967. 2 Errata in: PLoS Med. 2016.","DOI":"10.1371\/journal.pmed.1002066"},{"key":"key-10.3201\/eid2506.181928-201905191612-R6","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/S1473-3099(15)00144-9","article-title":"Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.","volume":"15","author":"Hunt","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2506.181928-201905191612-R7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4049\/jimmunol.0901231","article-title":"Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis.","volume":"184","author":"Bradfute","year":"2010","journal-title":"J Immunol"},{"key":"key-10.3201\/eid2506.181928-201905191612-R8","doi-asserted-by":"crossref","unstructured":"Geisbert TW, Mire CE, Geisbert JB, Chan Y-P, Agans KN, Feldmann F,  Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Sci Transl Med. 2014;6:242ra82.","DOI":"10.1126\/scitranslmed.3008929"},{"key":"key-10.3201\/eid2506.181928-201905191612-R9","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever.","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2506.181928-201905191612-R10","article-title":"Reference intervals for hematology and clinical chemistry of strain 13\/N guinea pigs (Cavia porcellus).","author":"Genzer","journal-title":"J Am Assoc Lab Anim Sci"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/25\/6\/18-1928_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:29:02Z","timestamp":1732987742000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/25\/6\/18-1928_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2506.181928","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}